Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Just Some Food for Thought
View:
Post by redatnight on Aug 22, 2015 1:38pm

Just Some Food for Thought

              Possibe Scenarios for Telesta Share Price in 2020
       
  Good Better Best
Price/Dose MCNA $2,000 $2,500 $3,000
# Doses/Patient 16 20 24
Revenue/Patient $32,000 $50,000 $72,000
# New Pat./yr. 25,000 30,000 35,000
Revenue (000) $800,000 $1,500,000 $2,520,000
Profit Margin 10% 15% 20%
Profit $80,000 $225,000 $504,000
Shares Outst.(000) 400,000 350,000 300,000
Earnings/Share $0.20 $0.64 $1.68
P/E Ratio 8 10 12
Share Price $1.60 $6 $20
Comment by beechguy on Aug 22, 2015 2:59pm
Nice work Redatnight. 4 things I would change: 1) 2020- I assume you are referring to arriving at peak revenue by 2020. The market will attach a valuation based on potential peak revenue long before 2020. They will also attach a growth multiple if they see potential for off label, EU approval and sales etc. 2) Berendt said doses were going to be $3000, and then at the AGM stated that $4000 was ...more  
Comment by cheetio on Aug 22, 2015 3:45pm
Possibe Scenarios for Telesta 2015.......defuked
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities